AAPL281.62-2.17 (-0.76%) ▼|ABBV253.74+0.39 (+0.15%) ▲|ABT93.48-0.64 (-0.68%) ▼|ACN125.21-3.77 (-2.92%) ▼|ADBE205.52+2.79 (+1.38%) ▲|AMAT697.81+70.97 (+11.32%) ▲|AMD537.18+15.60 (+2.99%) ▲|AMGN359.53+1.20 (+0.33%) ▲|AMT169.07-6.52 (-3.71%) ▼|AMZN240.98+8.29 (+3.56%) ▲|AVGO375.57+10.55 (+2.89%) ▲|AXP340.57+0.21 (+0.06%) ▲|BA214.78-2.48 (-1.14%) ▼|BAC58.14+0.26 (+0.44%) ▲|BKNG184.63+3.17 (+1.74%) ▲|BLK949.75-14.96 (-1.55%) ▼|BMY57.68+0.16 (+0.27%) ▲|BNY144.77+1.21 (+0.84%) ▲|BRK-B497.68-0.98 (-0.20%) ▼|C142.97+1.21 (+0.85%) ▲|CAT1,019.18+21.71 (+2.18%) ▲|CL91.52-0.55 (-0.60%) ▼|CMCSA24.78+1.61 (+6.93%) ▲|COF202.53-1.47 (-0.72%) ▼|COP104.59-1.37 (-1.29%) ▼|COST954.12+1.58 (+0.17%) ▲|CRM159.10+0.73 (+0.46%) ▲|CSCO117.49+3.72 (+3.27%) ▲|CVS104.22-0.12 (-0.12%) ▼|CVX168.87-2.19 (-1.28%) ▼|DE614.43+1.19 (+0.19%) ▲|DHR193.13-3.07 (-1.56%) ▼|DIS99.10+0.31 (+0.31%) ▲|DUK128.02-0.39 (-0.30%) ▼|EMR142.25-1.24 (-0.86%) ▼|FDX323.15+4.62 (+1.45%) ▲|GD350.29+3.58 (+1.03%) ▲|GE373.97+4.97 (+1.35%) ▲|GEV1,085.90+40.73 (+3.90%) ▲|GILD126.13-1.75 (-1.37%) ▼|GM77.57-0.53 (-0.68%) ▼|GOOG349.67+14.98 (+4.47%) ▲|GOOGL351.62+14.23 (+4.22%) ▲|GS1,022.97+3.36 (+0.33%) ▲|HD347.86-1.00 (-0.29%) ▼|HON237.93-5.49 (-2.25%) ▼|IBM274.26+2.63 (+0.97%) ▲|INTC125.84-2.48 (-1.93%) ▼|INTU268.35+0.63 (+0.23%) ▲|ISRG405.81+1.54 (+0.38%) ▲|JNJ255.38+0.72 (+0.28%) ▲|JPM331.47+2.42 (+0.74%) ▲|KO82.91+0.28 (+0.34%) ▲|LIN508.81-10.81 (-2.08%) ▼|LLY1,210.75+2.63 (+0.22%) ▲|LMT504.69-2.71 (-0.53%) ▼|LOW220.25-2.23 (-1.00%) ▼|LRCX409.96+30.87 (+8.14%) ▲|MA510.18+11.16 (+2.24%) ▲|MCD266.65-3.11 (-1.15%) ▼|MDLZ59.88-0.91 (-1.50%) ▼|MDT81.46+0.48 (+0.59%) ▲|META564.60+14.35 (+2.61%) ▲|MMM163.85-0.17 (-0.10%) ▼|MO73.38-0.41 (-0.56%) ▼|MRK128.99+0.33 (+0.25%) ▲|MS213.25+1.22 (+0.58%) ▲|MSFT371.38-1.59 (-0.43%) ▼|MU1,093.91-38.42 (-3.39%) ▼|NEE87.54-1.03 (-1.16%) ▼|NFLX75.19+1.38 (+1.87%) ▲|NKE41.23+0.48 (+1.17%) ▲|NOW100.79+2.45 (+2.49%) ▲|NVDA193.91+1.38 (+0.72%) ▲|ORCL149.04+0.51 (+0.34%) ▲|PEP139.07-2.32 (-1.64%) ▼|PFE24.17-0.12 (-0.49%) ▼|PG147.47-1.55 (-1.04%) ▼|PLTR115.77+2.84 (+2.51%) ▲|PM180.45-0.32 (-0.18%) ▼|QCOM191.79+2.40 (+1.27%) ▲|RTX188.03+0.04 (+0.02%) ▲|SBUX103.23-1.37 (-1.31%) ▼|SCHW90.99+0.32 (+0.35%) ▲|SO96.86-0.31 (-0.31%) ▼|SPG225.53-1.36 (-0.60%) ▼|T21.52-1.21 (-5.30%) ▼|TMO503.37-9.67 (-1.88%) ▼|TMUS174.00-8.68 (-4.75%) ▼|TSLA399.97+20.26 (+5.34%) ▲|TXN286.92+1.50 (+0.52%) ▲|UBER75.58-0.62 (-0.81%) ▼|UNH418.00-9.89 (-2.31%) ▼|UNP271.49+3.14 (+1.17%) ▲|UPS107.24-0.91 (-0.84%) ▼|USB61.48+0.57 (+0.93%) ▲|V341.64+5.41 (+1.61%) ▲|VZ43.30-3.25 (-6.97%) ▼|WFC84.27+0.41 (+0.49%) ▲|WMT114.68-1.01 (-0.87%) ▼|XOM135.76-0.78 (-0.57%) ▼|AAPL281.62-2.17 (-0.76%) ▼|ABBV253.74+0.39 (+0.15%) ▲|ABT93.48-0.64 (-0.68%) ▼|ACN125.21-3.77 (-2.92%) ▼|ADBE205.52+2.79 (+1.38%) ▲|AMAT697.81+70.97 (+11.32%) ▲|AMD537.18+15.60 (+2.99%) ▲|AMGN359.53+1.20 (+0.33%) ▲|AMT169.07-6.52 (-3.71%) ▼|AMZN240.98+8.29 (+3.56%) ▲|AVGO375.57+10.55 (+2.89%) ▲|AXP340.57+0.21 (+0.06%) ▲|BA214.78-2.48 (-1.14%) ▼|BAC58.14+0.26 (+0.44%) ▲|BKNG184.63+3.17 (+1.74%) ▲|BLK949.75-14.96 (-1.55%) ▼|BMY57.68+0.16 (+0.27%) ▲|BNY144.77+1.21 (+0.84%) ▲|BRK-B497.68-0.98 (-0.20%) ▼|C142.97+1.21 (+0.85%) ▲|CAT1,019.18+21.71 (+2.18%) ▲|CL91.52-0.55 (-0.60%) ▼|CMCSA24.78+1.61 (+6.93%) ▲|COF202.53-1.47 (-0.72%) ▼|COP104.59-1.37 (-1.29%) ▼|COST954.12+1.58 (+0.17%) ▲|CRM159.10+0.73 (+0.46%) ▲|CSCO117.49+3.72 (+3.27%) ▲|CVS104.22-0.12 (-0.12%) ▼|CVX168.87-2.19 (-1.28%) ▼|DE614.43+1.19 (+0.19%) ▲|DHR193.13-3.07 (-1.56%) ▼|DIS99.10+0.31 (+0.31%) ▲|DUK128.02-0.39 (-0.30%) ▼|EMR142.25-1.24 (-0.86%) ▼|FDX323.15+4.62 (+1.45%) ▲|GD350.29+3.58 (+1.03%) ▲|GE373.97+4.97 (+1.35%) ▲|GEV1,085.90+40.73 (+3.90%) ▲|GILD126.13-1.75 (-1.37%) ▼|GM77.57-0.53 (-0.68%) ▼|GOOG349.67+14.98 (+4.47%) ▲|GOOGL351.62+14.23 (+4.22%) ▲|GS1,022.97+3.36 (+0.33%) ▲|HD347.86-1.00 (-0.29%) ▼|HON237.93-5.49 (-2.25%) ▼|IBM274.26+2.63 (+0.97%) ▲|INTC125.84-2.48 (-1.93%) ▼|INTU268.35+0.63 (+0.23%) ▲|ISRG405.81+1.54 (+0.38%) ▲|JNJ255.38+0.72 (+0.28%) ▲|JPM331.47+2.42 (+0.74%) ▲|KO82.91+0.28 (+0.34%) ▲|LIN508.81-10.81 (-2.08%) ▼|LLY1,210.75+2.63 (+0.22%) ▲|LMT504.69-2.71 (-0.53%) ▼|LOW220.25-2.23 (-1.00%) ▼|LRCX409.96+30.87 (+8.14%) ▲|MA510.18+11.16 (+2.24%) ▲|MCD266.65-3.11 (-1.15%) ▼|MDLZ59.88-0.91 (-1.50%) ▼|MDT81.46+0.48 (+0.59%) ▲|META564.60+14.35 (+2.61%) ▲|MMM163.85-0.17 (-0.10%) ▼|MO73.38-0.41 (-0.56%) ▼|MRK128.99+0.33 (+0.25%) ▲|MS213.25+1.22 (+0.58%) ▲|MSFT371.38-1.59 (-0.43%) ▼|MU1,093.91-38.42 (-3.39%) ▼|NEE87.54-1.03 (-1.16%) ▼|NFLX75.19+1.38 (+1.87%) ▲|NKE41.23+0.48 (+1.17%) ▲|NOW100.79+2.45 (+2.49%) ▲|NVDA193.91+1.38 (+0.72%) ▲|ORCL149.04+0.51 (+0.34%) ▲|PEP139.07-2.32 (-1.64%) ▼|PFE24.17-0.12 (-0.49%) ▼|PG147.47-1.55 (-1.04%) ▼|PLTR115.77+2.84 (+2.51%) ▲|PM180.45-0.32 (-0.18%) ▼|QCOM191.79+2.40 (+1.27%) ▲|RTX188.03+0.04 (+0.02%) ▲|SBUX103.23-1.37 (-1.31%) ▼|SCHW90.99+0.32 (+0.35%) ▲|SO96.86-0.31 (-0.31%) ▼|SPG225.53-1.36 (-0.60%) ▼|T21.52-1.21 (-5.30%) ▼|TMO503.37-9.67 (-1.88%) ▼|TMUS174.00-8.68 (-4.75%) ▼|TSLA399.97+20.26 (+5.34%) ▲|TXN286.92+1.50 (+0.52%) ▲|UBER75.58-0.62 (-0.81%) ▼|UNH418.00-9.89 (-2.31%) ▼|UNP271.49+3.14 (+1.17%) ▲|UPS107.24-0.91 (-0.84%) ▼|USB61.48+0.57 (+0.93%) ▲|V341.64+5.41 (+1.61%) ▲|VZ43.30-3.25 (-6.97%) ▼|WFC84.27+0.41 (+0.49%) ▲|WMT114.68-1.01 (-0.87%) ▼|XOM135.76-0.78 (-0.57%) ▼|
30.5 C
New York
Monday, June 29, 2026

Tag: guidance

BRĒZ THC Drinks Update: 2025 Launch Expands Access to Legal Microdosed THC Beverage Line

In this 2025 product availability update, BRĒZ shares how its legal microdosed THC drinks are redefining the fast-growing functional beverage space—offering adults new access to non-alcoholic, hemp-derived cannabis tonics aligned with the search for the best THC drink alternatives.
In this 2025 product availability update, BRĒZ shares how its legal microdosed THC drinks are redefining the fast-growing functional beverage space—offering adults new access to non-alcoholic, hemp-derived cannabis tonics aligned with the search for the best THC drink alternatives.

AHC Hardwood Group Announces CEO Transition after More than 70 Years of Family Leadership

ATLANTA, July 8, 2025 /PRNewswire/ -- After four decades of dedicated leadership, Jim Howard, CEO of Atlanta Hardwood Corporation, recently rebranded as AHC Hardwood...

XRP Boom 2025: Daily Cloud Mining Contracts Now Live with DRML Miner

DRML Miner introduces automated XRP rewards with AI-optimized contract options
DRML Miner introduces automated XRP rewards with AI-optimized contract options

Native Hydrate Variety Pack Delivers Sugar-Free Hydration with Full Electrolyte Profile and Nine Essential Amino Acids

Clean-label hydration meets real-world functionality in NativePath’s new stick pack assortment featuring natural flavors, third-party tested ingredients, and a complete hydration matrix designed for daily wellness.
Clean-label hydration meets real-world functionality in NativePath’s new stick pack assortment featuring natural flavors, third-party tested ingredients, and a complete hydration matrix designed for daily wellness.

New Fat Burner for Women Launched Over the Counter – PhenQ Medically Accredited Fat Burning Supplement

Clinicians’ Choice Fat Burner for Women, PhenQ: Clinically Endorsed by 800 Healthcare Professionals Launched Over the Counter in the USA and Worldwide.
Clinicians’ Choice Fat Burner for Women, PhenQ: Clinically Endorsed by 800 Healthcare Professionals Launched Over the Counter in the USA and Worldwide.

Native Creatine Responds to 2025 Surge in Creatine Interest Among Women Over 50 Seeking Non-Gym Solutions

NativePath’s Clean-Label Creatine Powder Combines L-Leucine, L-Carnitine, and Creatine Monohydrate for Daily Muscle and Energy Support Without Resistance Training
NativePath’s Clean-Label Creatine Powder Combines L-Leucine, L-Carnitine, and Creatine Monohydrate for Daily Muscle and Energy Support Without Resistance Training

ZyVersa Therapeutics Announces a Warrant Inducement Transaction for $2.0 Million in Gross Proceeds

WESTON, Fla., July 08, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of patients with renal and inflammatory diseases who have unmet medical needs, today announced its entry into a warrant inducement agreement with a single institutional investor of the Company. Terms of the warrant inducement agreement include the immediate exercise of Series A-2 Warrants to purchase up to 957,200 shares of common stock (the “Series A-2 Warrants”) and Series A-3 Warrants to purchase up to 2,105,265 shares of common stock (the “Series A-3 Warrants,” and together with the Series A-2 Warrants, the “Existing Warrants”) at a reduced exercise price of $0.67. Gross cash proceeds were approximately $2.0 million before deducting financial advisor fees and other transaction expenses. The Company intends to use the net proceeds from the offering for working capital and other general corporate purposes.

Allegheny Health Network appoints two leaders to key executive roles

New chief operating officer, chief quality officer added to core AHN c-suite team led by recently appointed president Mark Sevco PITTSBURGH, July 8, 2025 /PRNewswire/...

Biotia Partners with Leading Korean Pharmaceutical Company to Advance Infectious Disease Diagnostics in Remote Regions — Including in Space

QUEENS, N.Y., July 8, 2025 /PRNewswire/ -- Biotia, a biotechnology company pioneering the development of novel infectious disease diagnostics, today announced its selection as...

We Sell Restaurants Secures a Memorandum of Understanding with FSC Franchise Co.

Nation's Largest & Only Restaurant Broker Franchise Touts Re-Sale Agreement with FSC's Portfolio of Restaurants PALM COAST, Fla., July 8, 2025 /PRNewswire/ -- We Sell Restaurants,...

HealthBook+ Launches PaiGE™, a Groundbreaking AI Health Assistant Bridging the Gap Between Patient Visits

All-in-one, intelligent healthcare platform empowers patients and clinicians with instant insights, tailored support, and streamlined care. DENVER, July 8, 2025 /PRNewswire/ -- HealthBook+, a leader in...

BloodVitals Pulse Oximeter 2025 Release Reinforces Pain-Free, Real-Time Monitoring of Blood Vitals with Hospital-Grade Precision at Home

In this 2025 product transparency update, BloodVitals details how its pulse oximeter supports real-time blood vitals tracking through non-invasive technology designed for seniors and at-home wellness users. The release explores the shift toward pain-free health monitoring, the rising demand for accessible oxygen level tools, and the increasing role of pulse oximeters in managing vital signs outside clinical settings.
In this 2025 product transparency update, BloodVitals details how its pulse oximeter supports real-time blood vitals tracking through non-invasive technology designed for seniors and at-home wellness users. The release explores the shift toward pain-free health monitoring, the rising demand for accessible oxygen level tools, and the increasing role of pulse oximeters in managing vital signs outside clinical settings.

Hospital PMI® at 49%; June 2025 Hospital ISM® Report On Business®

TEMPE, Ariz., July 8, 2025 /PRNewswire/ -- Economic activity in the hospital subsector contracted in June after 21 consecutive months of growth, say the nation's...

SAPPHIRE WINDOWS FOR AEROSPACE & MILITARY APPLICATIONS

PROVIDENCE, R.I., July 8, 2025 /PRNewswire/ -- Meller Optics, Inc. has introduced custom fabricated sapphire windows, lenses, and domes that exhibit extreme hardness, chemical resistance,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsGuidance